9711b34j

Our Approach

We started ETX Pharma to develop safe drugs to patients with serious gastrointestinal diseases. Our guiding principles are to develop and commercialize drugs that treat underlying cause of disease with friendly oral formulation.

Our Story

ETX was founded in 2014 by a seasoned team of entrepreneurs and leading medical experts to provide novel drugs to patients long suffering with serious gastrointestinal diseases and often dangerous or ineffective drugs

Meet the Team

Please meet the key people building ETX Pharma, Inc into a global leader in the treatment of major gastrointestinal diseases

Dr Craig M Liddell

President & CEO

Dr Liddell has over two decades in the biotechnology industry with several successful exits in Genomics, Cardiovascular disease, Oncology and Gastrointestinal Disease. He was a Senior Executive for an IPO in 2001 after a successful academic career as Senior Editor and reviewer for several high profile journals and NIH and  NSF grants programs. He actively volunteers on several community organizations in Northern Virginia.

Dr Christine Copple

Chief Operating Officer

Over two decades as a corporate officer Chris has managed fund raising, business development, and operations from cGMP build/design to investor relations and R&D.  She is a Board Member of the Washington D.C. ArchAngels where she Chairs their Bio-Life Science Caucus

Dr Ralph Scannell

VP Chemistry

Dr. Scannell has more than 30 years of experience in the pharmaceutical/biotechnology industry where he held several leadership roles in drug discovery and development in multiple therapeutic areas.  He was responsible for delivering several drug candidates into preclinical development and three drugs into clinical development.

Next Steps...

If you are interested in ETX Pharma, Inc and wish to receive more information please contact us...